Personalized Medicine, Genetic Testing Could Shape the Future of Non-Small Cell Lung Cancer

While identifying new genetic targets and developing new drugs is important for the future of non-small cell lung cancer (NSCLC), more emphasis should be put on improving patient access to existing targeted treatments, according to Dr. Nathan A. Pennell.


CURE: Combining science and humanity to make cancer understandable.